Time to watch: How Timber Pharmaceuticals (TMBR) shares jumped in the AH session

MRAI Stock
MRAI Stock

Timber Pharmaceuticals (NYSE: TMBR) rose 23.97% to $1.5 in the after-market session. This stock has wildly shifted this year, with buyers keen to raise stock rates for simple business news or no news at all.

Nevertheless, on December 10, 2020, A biopharmaceutical corporation focusing on the production and commercialization of therapies for rare and orphan dermatological disorders revealed that it would host a corporate update conference call for analysts and shareholders.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Timber’s Chief Executive Officer, John Koconis, and Chief Financial Officer, Joe Lucchese, will host the call.

Conference Call Information

It will be held on Thursday, December 17th, at 11:00 am EST. 

To join the call: Contact (877) 270-2148 and ask to be joined into the Timber Pharmaceuticals call. 

There will also be a live webcast of the conference call, which can be accessed at: 

https://services.choruscall.com/links/timberpharma201217.html For those unable to 

participate in the live conference call; a replay will be archived and available on 

Timber’s website under the Investor Relations tab at www.timberpharma.com.


Please enter your comment!
Please enter your name here